Table 2.

Long-acting opioids prescribed within 30 days of nursing home admission, by presence of short-acting opioid claim in prior 60 days

	Nursing home residents, %
	Long-acting opioids prescribed without evidence of a short-acting opioid claim in prior 60 days (n = 1,052)	Long-acting opioids prescribed with evidence of a short-acting opioid claim in prior 60 days (n = 11,226)
First long-acting opioid	Percentage
Buprenorphine	0.6	0.2
Transdermal fentanyl	51.9	56.4
Hydromorphone	0.1	0.0
Morphine sulfate	28.1	23.2
Oxycodone	17.2	18.5
Oxymorphone	0.8	0.6
Tramadol	1.3	1.0
	Percentage
Buprenorphine	(n = 6)	(n = 24)
5 MCG/HR	66.7	66.7
10 MCG/HR	33.3	25.0
20 MCG/HR	0.0	8.3
Transdermal fentanyl	(n = 546)	(n = 6,327)
12 MCG/HR	26.7	25.9
25 MCG/HR	37.8	38.6
50 MCG/HR	20.5	19.7
75 MCG/HR	8.8	8.8
100 MCG/HR	6.4	7.0
Hydromorphone	(n = 1)	(n = 5)
8 MG	0.0	40.0
12 MG	0.0	20.0
16 MG	100.0	40.0
Morphine sulfate	(n = 296)	(n = 2,609)
≤15 MG	54.0	58.1
20 – 30 MG	30.4	29.2
>30 MG	15.6	12.7
Oxycodone	(n = 181)	(n = 2,080)
≤15 MG	65.0	58.7
20 – 30 MG	20.0	27.5
>30 MG	15.0	13.8
Oxymorphone	(n = 8)	(n = 71)
5 MG	50.0	11.3
7.5 – 10 MG	12.5	18.3
15 MG	0.0	9.9
20 – 30 MG	12.5	43.7
>30 MG	25.0	16.9
Tramadol	(n = 14)	(n = 110)
100 MG	71.4	70.0
200 MG	28.6	25.5
300 MG	0.0	4.6

^a Represents the prescription that identified the nursing home resident as having received a long-acting opioid after admission.